Accelerate precision probiotic therapies by identifying person-specific features affecting probiotic responses to enhance clinical outcomes.
This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.
This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.
This grant funds further development and validation of new molecular and cellular analysis technologies to improve basic and clinical cancer research, excluding projects using existing technologies for new targets.